International journal of surgery (London, England)
Efficacy and safety of TACE plus lenvatinib with PD-1 inhibitor for unresectable huge hepatocellular carcinoma: a multicenter retrospective cohort study.
Ye Liang, Jingyu Yang, Hui Li, Jingxi Wu, Wenle Tan, Yigong Ren, Xiaohui Li, Ruixia Li, Xiaohui Wang, Mingyu Liu, Qunfang Zhou, Feng Duan
Published: 202510.1097/JS9.0000000000004131
Abstract
PURPOSE: The combination of transarterial chemoembolization (TACE) plus lenvatinib and programmed death receptor-1 (PD-1) inhibitor has shown promising results for advanced hepatocellular carcinoma (HCC), but its benefits for unresectable huge HCC (m…
Preview only. Read the full abstract at the source